APP and Alzheimer disease: Increased generation of reactive oxygen species (ROS) in the brain of AD patients is a direct consequence of Aβ-induced toxicity, which is triggered by the amyloidogenic processing of the amyloid precursor protein (APP) by sequential β-secretase and γ-secretase cleavage [4,5].